NEW YORK (GenomeWeb News) — The Autism Consortium has released raw genotype data from its genome-wide scans of 3,000 children with autism spectrum disorders or their families, the consortium said Monday.
The Autism Gene Discovery program used Affymetrix’s 500K microarrays to study DNA samples provided by the Autism Genetic Resource Exchange, which is a program begun by the group Autism Speaks.
The genomic data now will be deposited in AGRE’s gene bank, which will be made available to qualified researchers, according to the consortium, which comprises researchers, clinicians, and families.
“We’re releasing raw genotype data so that other qualified researchers can take a look at it even as we’re still beginning our own analysis,” statistical geneticist and consortium member Mark Daly said in a statement.
The genome-wide scan program was initiated in part due to a “growing agreement in the research community that genes have a significant role in autism spectrum disorders,” the Autism Consortium said.
The consortium said its Gene Discovery Group has found what “may be important new information on the genes involved in autism spectrum disorders,” and that now the research aim will be to conduct association analysis to try to discover what role the genetic variations play in these disorders.